Billionaire Phillipe Laffont Sold Coatue Management's Stake in Super Micro Computer and Snapped Up This Surgical Robotics Pioneer That's Up 19,390% Since Its IPO

Coatue Management, overseeing approximately $35 billion, made significant portfolio adjustments in Q2, fully divesting from Super Micro Computer while substantially increasing its stake in robot-assisted surgery pioneer Intuitive Surgical (ISRG) by acquiring 39,512 shares. This strategic move into ISRG comes as the stock has declined about 26% from its February peak due to tariff concerns and competitive fears; however, the article highlights ISRG's dominant market position, high customer switching costs, robust recurring revenue streams, and management's forecast of 15.5%-17.0% procedure growth, suggesting a strong long-term outlook despite its premium valuation.

Analysis

Coatue Management's second-quarter portfolio adjustment signals a notable strategic rotation, completely divesting from custom server builder Super Micro Computer while establishing a new position in Intuitive Surgical (ISRG) with the acquisition of 39,512 shares. This move into ISRG is particularly contrarian, as the stock has declined approximately 26% from its February peak. The rationale appears rooted in ISRG's fundamental strengths: a dominant market position with over 11,040 installed da Vinci systems, high customer switching costs, and a powerful recurring revenue stream that constituted 84% of total revenue last year. Despite near-term headwinds from tariffs—which prompted management to lower its adjusted gross profit margin guidance to a 66%-67% range from 69.1% last year—the company projects robust procedure growth of 15.5% to 17.0% for this year. While competitive threats exist, particularly from Medtronic's Hugo system in the urology space, its lackluster European launch and the recent introduction of ISRG's next-generation da Vinci 5 system suggest Intuitive's market leadership remains secure. However, the stock's premium valuation at 55.3 times forward earnings indicates that high growth expectations are already priced in, leaving little room for operational missteps.

Key Decisions for Investors

• Consider the recent 26% pullback in Intuitive Surgical's stock as a potential entry point for a long-term position, given its durable competitive moat and strong recurring revenue model.
• Investors should closely monitor ISRG's gross margins for further compression from tariffs and track any announcements regarding the adoption rate of Medtronic's Hugo system in the U.S., as these are the primary risks to the investment thesis.
• Recognize that ISRG's high forward P/E of 55.3x requires sustained double-digit procedure growth; any failure to meet the guided 15.5%-17.0% growth could lead to significant price volatility.
• Note Coatue Management's complete Q2 exit from Super Micro Computer as a significant bearish signal from a prominent technology-focused hedge fund, which may warrant a reassessment of long positions in SMCI.